Emmanuel Enrici’s practice focuses on sponsor-side private equity transactions, including large-cap buyouts, carveouts, and exits.

He has experience in all areas of corporate law and advises private equity sponsors, sovereign wealth funds, and corporates on leveraged buyouts, private equity acquisitions, fund investments, strategic acquisitions, and divestitures.

Emmanuel joined the firm as a partner in 2026 from another major international law firm.

 
Read More

Notable Experience (including those prior to joining Cleary)

  • Advent International in its acquisition of Kereis.

  • Providence Equity Partners in:

    • Its acquisition of a majority stake in Groupe La Centrale.
    • Its sale of La Centrale for €1.1 billion.
    • Its investment in A2MAC1.

  • GTCR in its acquisition of a majority stake in Worldpay, followed by the $24.25 billion sale of Worldpay to Global Payments as part of a transformative three-way transaction.

  • Continental Grain Company in:

    • Its investment in Cérélia.
    • Its investment and reinvestment in Ceva Santé Animale.

  • Clayton, Dubilier & Rice (CD&R) in its acquisition of a 50% controlling stake in Opella from Sanofi, for an enterprise value of €16 billion.

  • Clearlake Capital Group in its acquisition of MV Credit, a pan-European private credit specialist, from Natixis Investment Managers, a global multi-strategy asset manager.

  • TPG in its €3.9 billion acquisition of Aareon.

  • Gallant Capital in its acquisition of Fime and its combination with UL Solutions’ payments testing business.

  • IK Partners in the sale of a controlling interest in the firm to Wendel.

  • Vantiva Technologies in the implementation of an €85 million bridge facility.

  • Oaktree Capital Management and its portfolio company Boardriders in its sale to Authentic Brands.

  • Wendel in its acquisition of Scalian Group.

  • Thomas H. Lee Partners and Frazier Healthcare Partners in the sale of Adare Biome.

  • Thoma Bravo and its portfolio company Cority in its acquisition of Reporting 21.

  • Partners Group in its investment alongside Montagu in connection with the acquisition of HTL Biotechnology.

  • EQT Private Equity and its portfolio company IVC Evidensia in:

    • Its acquisition of VetOne group.
    • Its acquisition of a majority stake in Veternity.

  • Goldman Sachs in:

    • The sale of Talentsoft.
    • Its acquisition of B&B Hotels.

  • Vista Equity Partners and its portfolio company iCIMS in its acquisition of EASYRECRUE.

  • West Street Capital Partners VII and other shareholders in the sale of Groupe Meilleurtaux, a French financial services provider.

  • CPP Investments and its consortium partners in its acquisition of Galileo Global Education.

  • Stirling Square in its sale of Siblu Villages to Naxicap.

  • Intermediate Capital Group in its acquisition of Stella Group, followed by its sale to PAI Partners.

  • TA Associates in:

    • Its acquisition of Odealim group from Eurazeo.
    • Its sale of Ciprès group to Apax Partners.
    • Its acquisition of a minority stake in Babilou Group.

  • PSP Investments in its acquisition of a minority stake in Fives Group.

  • Ardian in:

    • Its acquisition of Hypred Group, followed by the bolt-on acquisition of Anti-Germ International.
    • Its sale of Novacap Group to Eurazeo.
See More